These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 409561)

  • 21. Effects of phenobarbital and diphenylhydantoin on acute vitamin D3 toxicity in the rat.
    Gascon-Barré M; Côté MG
    Toxicol Appl Pharmacol; 1978 Jan; 43(1):125-35. PubMed ID: 204079
    [No Abstract]   [Full Text] [Related]  

  • 22. The effect of phenobarbital on diphenylhydantoin metabolism in children.
    Buchanan RA; Heffelfinger JC; Weiss CF
    Pediatrics; 1969 Jan; 43(1):114-6. PubMed ID: 5764058
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential attenuation of somatovisceral and viscerosomatic reflexes by diazepam, phenobarbital and diphenylhydantoin.
    Schlosser W; Franco S; Sigg EB
    Neuropharmacology; 1975 Jul; 14(7):525-31. PubMed ID: 1153095
    [No Abstract]   [Full Text] [Related]  

  • 24. Effects of phenobarbital or SKF 525A pretreatment on diphenylhydantoin disposition in pregnant mice.
    Harbison RD; Becker BA
    Toxicol Appl Pharmacol; 1971 Dec; 20(4):573-81. PubMed ID: 5143597
    [No Abstract]   [Full Text] [Related]  

  • 25. [Serum beta-glucuronidase activity in patients treated with phenobarbital and diphenylhydantoin].
    Tutor JC; Fernández MP; Paz JM
    Arch Farmacol Toxicol; 1982 Apr; 8(1):37-44. PubMed ID: 7138085
    [No Abstract]   [Full Text] [Related]  

  • 26. Low-affinity kainate receptor-mediated events reduce the protective activity of phenobarbital and diphenylhydantoin against maximal electroshock in mice.
    Borowicz KK; Zadrozniak M; Czuczwar SJ
    Neuropharmacology; 2002 Dec; 43(7):1082-6. PubMed ID: 12504914
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against phenylisothiocyanate by various steroids, phenobarbitone and diphenylhydantoin.
    Selye H; Szabo S; Kourounakis P
    J Pharm Pharmacol; 1972 Apr; 24(4):333-4. PubMed ID: 4402846
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of diphenylhydantoin and phenobarbital on protein metabolism in the rat cerebral cortex.
    Jones GL; Woodbury DM
    Biochem Pharmacol; 1976 Jan; 25(1):53-61. PubMed ID: 1252257
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of phenobarbital and diphenylhydantoin on different lipid fractions of liver].
    Ariyoshi T; Remmer H
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 260(2):90-1. PubMed ID: 4239254
    [No Abstract]   [Full Text] [Related]  

  • 30. Enhancement by phenobarbital and diphenylhydantoin of carbon monoxide production in normal man.
    Coburn RF
    N Engl J Med; 1970 Sep; 283(10):512-5. PubMed ID: 5434134
    [No Abstract]   [Full Text] [Related]  

  • 31. Pituitary-adrenal responses to sub-chronic treatment with phenobarbital and/or phenytoin (diphenylhydantoin) in rats.
    Torrellas A; Guaza C; Borrell J; Borrell S
    Pharmacol Biochem Behav; 1981 Aug; 15(2):235-41. PubMed ID: 7312894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects on toes from prenatal exposure to anticonvulsants.
    Bokhari A; Connolly S; Coull BA; Harvey EA; Holmes LB
    Teratology; 2002 Sep; 66(3):122-6. PubMed ID: 12210473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teratological interaction between the bis-triazole antifungal agent fluconazole and the anticonvulsant drug phenytoin.
    Tiboni GM; Iammarrone E; Giampietro F; Lamonaca D; Bellati U; Di Ilio C
    Teratology; 1999 Feb; 59(2):81-7. PubMed ID: 10069438
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anticonvulsant effects of phenobarbital, diphenylhydantoin and two benzodiazepines in the baboon, Papio papio.
    Stark LG; Killam KF; Killam EK
    J Pharmacol Exp Ther; 1970 May; 173(1):125-32. PubMed ID: 4986083
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of inositol, diphenylhydantoin and phenobarbital on HEOD storage in rat adipose tissue.
    Cook RM
    Bull Environ Contam Toxicol; 1973 Jun; 9(6):370-5. PubMed ID: 4780440
    [No Abstract]   [Full Text] [Related]  

  • 36. Increased metabolism of metyrapone in rats pretreated with diphenylhydantoin or phenobarbital.
    Szeberenyi S; Tacconi MT; Garattini S
    Endocrinology; 1969 Sep; 85(3):575-6. PubMed ID: 5793035
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic tolerance of a new anticonvulsant agent (3-sulfamoylmethyl-1,2-benzisoxazole) compared to phenobarbital, diphenylhydantoin and carbamazepine in rats.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    Arch Int Pharmacodyn Ther; 1979 Jul; 240(1):79-89. PubMed ID: 507999
    [No Abstract]   [Full Text] [Related]  

  • 38. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
    Pietrasiewicz T; Czechowska G; Dziki M; Turski WA; Kleinrok Z; Czuczwar SJ
    Eur J Pharmacol; 1993 Nov; 250(1):1-7. PubMed ID: 7907019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of diphenylhydantoin and phenobarbital on intestinal calcium transport in the rat.
    Koch HU; Kraft D; von Herrath D; Schaefer K
    Epilepsia; 1972 Dec; 13(6):829-34. PubMed ID: 4509174
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on the glucaric acid pathway in the metabolism of D-glucuronic acid in mammals. V. Stimulatory effect of diphenylhydantoin and phenobarbital on the D-glucaric acid synthesis in man.
    Okada M; Matsui M; Kaizu T; Abe F
    Chem Pharm Bull (Tokyo); 1969 Dec; 17(12):2625-8. PubMed ID: 5373168
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.